Diabetes Obesity & Metabolism

González‐Juanatey, José R.

doi: 10.1046/j.1463-1326.2002.00165.xpmid: 11940104

Chowdhury, T. A.; Khan, T.

doi: 10.1046/j.1463-1326.2002.00101.xpmid: 11940105

Westergaard, N.; Madsen, P.; Lundbeck, J. M.; Jakobsen, P.; Varming, A.; Andersen, B.

doi: 10.1046/j.1463-1326.2002.00179.xpmid: 11940106

Aim: In this study, we show that inhibitors of the glucose‐6‐phosphatase (G‐6‐Pase) catalytic protein could be an alternative approach to the recent G‐6‐Pase T1‐translocase inhibitors to target this enzyme for the treatment of type 2 diabetes.

Heller, S. R.; Amiel, S. A.; Evans, M. L.; Kong, M.‐F.; Macdonald, I. A.; Peacey, S. R.

doi: 10.1046/j.1463-1326.2002.00186.xpmid: 11940107

Aim: Insulin lispro used in an intensive basal/bolus regimen produces equivalent glycaemic control to human‐soluble insulin but reduces rates of hypoglycaemia. We tested the hypothesis that the use of rapid‐acting analogues might prevent the development of defective hypoglycaemic counterregulation during intensive insulin therapy.

Maser, R. E.; Lenhard, M. J.

doi: 10.1046/j.1463-1326.2002.00188.xpmid: 11940108

Aim: Cardiovascular autonomic neuropathy is a serious complication of diabetes mellitus. Previous studies have revealed conflicting results with regard to the role of obesity and its effect on the performance of tests (e.g. RR‐variation during deep breathing) for the determination of the presence of cardiovascular autonomic dysfunction. The objective of this study was to determine if obesity affects the performance and the reproducibility of autonomic function tests.

Al‐Nozah, M.; Al‐Daghri, N.; Bartlett, W. A.; Al‐Attas, O.; Al‐Maatouq, M.; Martin, S. C.; Kumar, S.; Jones, A. F.

doi: 10.1046/j.1463-1326.2002.00191.xpmid: 11940109

Introduction: Plasma homocysteine (HCYS) concentration is believed to be an independent risk factor for atherosclerosis.

Hwang, I. K.; Go, V. L. W.; Harris, D. M.; Yip, I.; Song, M. K.

doi: 10.1046/j.1463-1326.2002.00195.xpmid: 11940110

Aim: The present study is designed to determine whether arachidonic acid (AA) plus zinc improves clinical signs of diabetes in genetically diabetic ob/ob mice.

Hernandez‐Valencia, M.; Carrillo Pacheco, A.

doi: 10.1046/j.1463-1326.2002.00201.xpmid: 11940111

Aim: This prospective study was undertaken to look at the frequency of hyperglycaemia in pregnant women who were without health benefits and did not receive prenatal specialist care, and to examine the relationship between fetal complications and the prenatal care received.

doi: 10.1046/j.1463-1326.2002.00213.xpmid: N/A